Monopar Therapeutics Stock (NASDAQ: MNPR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 60.00 / 110.98K |
Day Range | - - - |
52 Wk Range | 0.27 - 1.73 |
Market Cap | $11.26M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 1.6% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Monopar Therapeutics (NASDAQ:MNPR) through any online brokerage.
Other companies in Monopar Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Lumos Pharma (NASDAQ:LUMO) and Coeptis Therapeutics (NASDAQ:COEP).
There is no analysis for Monopar Therapeutics.
Monopar Therapeutics has a consensus price target of $9.75.
The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $0.6399 last updated July 23, 2024 at 7:35 PM EDT.
There are no upcoming dividends for Monopar Therapeutics.
Monopar Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Monopar Therapeutics.
Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.